                         SEQUENCE LISTING

<110>  ARCH Cancer Therapeutics, Inc.
	Robbins, Stephen Mark
       Rahn, Jennifer
       Senger, Donna Lorraine
 
<120>  Brain Tumor Targeting Peptides and Methods

<130>  08922117WO

<140>  Not Yet Assigned
<141>  Filed Herewith

<150>  US 13/152,214
<151>  2011-06-11

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  1
Ser Val Ser Val Gly Met Lys Pro Ser Pro Arg Pro 
1               5                   10          

<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  2
Gly Ile Ser Leu Ser Ser Tyr Leu Gln Ser Thr Gln 
1               5                   10          

<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  3
Glu His Met Ala Leu Thr Tyr Pro Phe Arg Pro Pro 
1               5                   10          

<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  4
His Trp Ala Pro Ser Met Tyr Asp Tyr Val Ser Trp 
1               5                   10          

<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  5
Arg Thr Val Pro Asp Tyr Thr Ala His Val Arg Thr 
1               5                   10          

<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  6
Ser Gly His Gln Leu Leu Leu Asn Lys Met Pro Asn 
1               5                   10          

<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  7
Thr Asn Ser Ile Trp Tyr Thr Ala Pro Tyr Met Phe 
1               5                   10          

<210>  8
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  8
Gly Met Ser Leu Ser Arg Gln Met Leu Trp Ser Leu 
1               5                   10          

<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  9
His Leu Phe Pro Gln Ser Asn Tyr Gly Gly His Ser 
1               5                   10          

<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide


<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa can be any naturally occurring amino acid

<400>  10
Cys Ile Gln Leu Ala Asn Pro Pro Arg Leu Xaa Gly 
1               5                   10          

<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  11
Pro Ser Pro His Arg Gln Arg Gln His Ile Leu Arg 
1               5                   10          

<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  12
Gln Thr Ile Arg Ile Ile Ile Arg Arg Ser Arg Thr 
1               5                   10          

<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  13
Ser Leu His Met Arg His Lys Arg Lys Pro Arg Arg 
1               5                   10          

<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  14
Ser Ser Arg Ser Met Gln Arg Thr Leu Ile Ile Ser 
1               5                   10          

<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  15
Ile Arg Ser Ile Arg Met Arg Arg Ile Leu Ile Leu 
1               5                   10          

<210>  16
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic BTIC targeting peptide

<400>  16
Lys Thr Ser Met Arg Pro Leu Ile Leu Ile His Ile 
1               5                   10          

<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic HIGC targeting peptide

<400>  17
Lys Lys Gly Thr Asn Ser Ile Trp Tyr Thr Ala Pro Tyr Met Phe 
1               5                   10                  15  

<210>  18
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic carrier peptide

<400>  18
Thr Phe Phe Tyr Gly Gly Ser Arg Gly Lys Arg Asn Asn Phe Lys Thr 
1               5                   10                  15      
Glu Glu Tyr 
            

<210>  19
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic carrier peptide

<400>  19
Thr Phe Phe Tyr Gly Gly Ser Arg Gly Arg Arg Asn Asn Phe Arg Thr 
1               5                   10                  15      
Glu Glu Tyr 
            
